To control for the effect of p53 status, in the absence of a suitable melanoma cell line we similarly created IER2-inducible 67NR mouse breast adenocarcinoma cells, which are p53-deficient (Fig. S2c) and likewise express very low endogenous levels of IER2 (Fig. 2c). This evidence concerns the gene TP53 and breast adenocarcinoma.